v1
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.
Identifier:nobleid.org/w1/20260515/FD8FD25E
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FD8FD25E)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims